Rocky Mountain Movement Disorders Center, PC

Englewood, Colorado 80113

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer's Disease Dementia, Constipation, Dementia With Lewy Bodies, Excessive Sleepiness, Huntington Disease, Huntington's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Multiple System Atrophy, Parkinson Disease, Parkinson's Disease, Pure Autonomic Failure

Studies at this site

• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale — Stopped early
• Synuclein-One Study — Completed
• Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation — Completed
• Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease — Stopped early
• Auricular Muscle Zone Stimulation for Parkinson Disease — Completed
• Development of Assessments for Later Stage HD — Status unconfirmed
• A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness — Completed
• FuRST 2.0 Cognitive Pre-testing - Round 2 — Completed
• FuRST 2.0 Cognitive Pre-Testing — Completed